Y-Intercept (Hong Kong) Ltd

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1772875 HONG KONG, K3

Position in BMRN

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$628,046

-$3,797,267 QoQ

Shares Held

10,976

-86.0% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#318

of 561 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $205,108,253 across 117 Biotechnology names. BMRN ranks #73 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	101,908	$10,865,430
2	MRNA	Moderna, Inc.	139,861	$9,794,465
3	BBIO	BridgeBio Pharma, Inc.	107,419	$8,000,567
4	AXSM	Axsome Therapeutics, Inc.	22,923	$5,610,862
5	IONS	Ionis Pharmaceuticals Inc	67,374	$5,342,084
6	ADMA	Adma Biologics, Inc.	573,581	$4,800,872
7	UPB	Upstream Bio, Inc.	693,555	$4,799,400
8	NRIX	Nurix Therapeutics, Inc.	192,434	$4,668,448

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$628,046	10,976	-86.0%	Shares	Sole	2026-07-14
2026-03-31	$4,425,313	78,338	-27.4%	Shares	Sole	2026-04-27
2025-12-31	$6,416,359	107,965	+19.3%	Shares	Sole	2026-02-13
2025-09-30	$4,901,967	90,509	-36.1%	Shares	Sole	2025-10-31
2025-06-30	$7,787,489	141,668	+3253.1%	Shares	Sole	2025-08-01
2025-03-31	$298,665	4,225	-10.3%	Shares	Sole	2025-05-06
2024-12-31	$309,654	4,711	-83.3%	Shares	Sole	2025-02-04
2024-09-30	$1,984,286	28,230	+200.8%	Shares	Sole	2024-11-15
2023-06-30	$813,405	9,384	-36.5%	Shares	Sole	2023-08-14
2022-12-31	$1,528,443	14,769	+224.2%	Shares	Sole	2023-02-14
2022-09-30	$386,212	4,556	-29.8%	Shares	Sole	2023-02-14
2022-03-31	$500,147	6,487	+129.8%	Shares	Sole	2022-05-16
2021-12-31	$249,412	2,823	-86.9%	Shares	Sole	2022-02-14
2021-06-30	$1,792,207	21,479	+320.9%	Shares	Sole	2021-08-26
2020-12-31	$447,482	5,103	—	Shares	Sole	2021-02-05
No filing history on record for this holder in this stock.